We provide you with 20 years of free, institutional-grade data for ERAS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ERAS. Explore the full financial landscape of ERAS stock.
| Reported Date | CIK | Ticker | Type |
|---|
Erasca Inc(NASDAQ:ERAS) 
Erasca is a clinical-stage, precision oncology company with a bold mission—to erase cancer. ... Our robust, rapidly advancing pipeline of promising therapeutic candidates has the potential to improve the treatment of a range of RAS/MAPK pathway-related cancers—and in turn, transform millions of live...
Website: https://www.erasca.com/
Founded: 2018
Full Time Employees: 102
CEO / Co-Founder: Jonathan E. Lim
Sector:
Industry:
Share this website to your friends
The information provided in this report about ERAS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.